Diebold Nixdorf, Incorporated
DBD · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $945,200 | $915,200 | $841,100 | $988,900 |
| % Growth | 3.3% | 8.8% | -14.9% | – |
| Cost of Goods Sold | $697,300 | $681,200 | $638,700 | $752,500 |
| Gross Profit | $247,900 | $234,000 | $202,400 | $236,400 |
| % Margin | 26.2% | 25.6% | 24.1% | 23.9% |
| R&D Expenses | $20,300 | $22,400 | $22,700 | $25,600 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $147,900 | $145,000 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $153,800 | $7,500 | $5,100 | $169,600 |
| Operating Expenses | $174,100 | $177,800 | $172,800 | $195,200 |
| Operating Income | $73,800 | $56,200 | $29,600 | $41,200 |
| % Margin | 7.8% | 6.1% | 3.5% | 4.2% |
| Other Income/Exp. Net | -$22,500 | -$38,700 | -$39,300 | -$29,300 |
| Pre-Tax Income | $51,300 | $17,500 | -$9,700 | $11,900 |
| Tax Expense | $9,600 | $4,800 | -$2,200 | $5,500 |
| Net Income | $41,100 | $12,200 | -$8,300 | $5,600 |
| % Margin | 4.3% | 1.3% | -1% | 0.6% |
| EPS | 1.1 | 0.33 | -0.22 | 0.15 |
| % Growth | 233.3% | 250% | -246.7% | – |
| EPS Diluted | 1.09 | 0.33 | -0.22 | 0.15 |
| Weighted Avg Shares Out | 37,100 | 37,200 | 37,600 | 37,600 |
| Weighted Avg Shares Out Dil | 37,500 | 37,500 | 37,600 | 37,600 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,100 | $2,500 | $1,500 | $2,200 |
| Interest Expense | $21,800 | $21,800 | $21,500 | $34,700 |
| Depreciation & Amortization | $31,700 | $31,200 | $33,900 | $43,300 |
| EBITDA | $104,800 | $70,200 | $48,000 | $132,400 |
| % Margin | 11.1% | 7.7% | 5.7% | 13.4% |